Pheronym®’s Nemastim™ Advances Biological Control of Whiteflies in Breakthrough Foliar Application
UF Innovate | Accelerate alum Pheronym®, an ag-biotech company in sustainable pest management, has announced that pheromones increased beneficial nematodes’ performance against whiteflies in a foliar application.
Oragenics, Inc. Announces Approval To Initiate Phase II Concussion Drug Trial in Australia
UF Innovate | Accelerate graduate Oragenics announced that it has received approval from the Human Research Ethics Committee (HREC) in Australia to initiate a Phase II clinical trial evaluating ONP-002 for the treatment of mild traumatic brain injury (mTBI).
Find Out Why Entrepreneurs in Gainesville Thrive Here
Gainesville’s thriving entrepreneurial ecosystem, supported by UF Innovate, is exemplified by the success of UF startup MYOLYN, known for its rehabilitation technology, and UF Innovate | Accelerate client Slice Engineering, a leader in 3D printing components.
Biotech Industry in Gainesville Is Booming
Gainesville’s booming biotech industry, bolstered by UF Innovate’s incubators and a supportive business environment, showcases the success of UF-affiliated startups and the city’s commitment to innovation and entrepreneurship.
NovaBone Announces Strategic Partnership With Summit Products Group To Distribute NovaForm® Wound Matrix in the U.S.
UF startup NovaBone Products, a leading developer of biomaterials for regenerative medicine, announced that it has entered into a long-term strategic partnership with Summit Products Group, a national provider of advanced wound care solutions.
Chiller Body Joins UF Innovate | Accelerate
Chiller Body joins UF Innovate | Accelerate at The Hub to drive the global expansion of its patented cooling hat inserts.
TECDIA Launches Ultra-Fine kaikaFIN Nozzle for Mako Hotend in Partnership With Slice Engineering
Japanese precision machining company TECDIA Co., Ltd. has unveiled the kaikaFIN, a next-generation 3D printing nozzle designed for the Mako Hotend by UF Innovate | Accelerate client Slice Engineering.
Oragenics, Inc. To Participate at the 15th Annual Traumatic Brain Injury Conference
UF Innovate | Accelerate graduate Oragenics, Inc., a biotechnology company developing novel intranasal therapies for concussion and other brain-related conditions, announced its participation in the 15th Annual Traumatic Brain Injury Conference.
The Fibrolamellar Cancer Foundation Establishes Partnership With Dialectic Therapeutics
UF startup Dialectic Therapeutics, in partnership with the Fibrolamellar Cancer Foundation (FCF), will supply the experimental drug DT2216 for a clinical trial involving fibrolamellar patients.
Oragenics, Inc. Announces Health and Disability Ethics Committee Submission for Phase IIa Concussion Trial
UF Innovate | Accelerate graduate Oragenics announced that it has submitted a clinical trial protocol for regulatory review to the Health and Disability Ethics Committee (HDEC) in New Zealand.